What Mural Oncology plc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 2 |
| Total trades | 0 | 6 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
Common stock only — 6 reported trades in the last 12 months are in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Cutler Adam D. | Chief Financial Officer | Dec 05 | Disposition to Issuer · D | −99,290 | — | — | 0 |
| Keson-Brookes Maiken | Chief Legal Officer | Dec 05 | Disposition to Issuer · D | −68,834 | — | — | 0 |
| Goodman Vicki L | Chief Medical Officer | Dec 05 | Disposition to Issuer · D | −84,727 | — | — | 0 |
| Loew Caroline | Chief Executive Officer | Dec 05 | Disposition to Issuer · D | −293,059 | — | — | 0 |
| Goodman Vicki L | Chief Medical Officer | Nov 10 | Open-market sale · S | −5,036 | $2.08 | −$10.5K | 84,727 |
| Cutler Adam D. | Chief Financial Officer | Nov 03 | Open-market sale · S | −7,148 | $2.09 | −$14.9K | 99,290 |
| Keson-Brookes Maiken | See Remarks | Jul 22 | Open-market sale · S | −2,572 | $2.48 | −$6.38K | 68,834 |
| Keson-Brookes Maiken | See Remarks | Jul 18 | Open-market sale · S | −2,158 | $2.48 | −$5.35K | 71,406 |
| Loew Caroline | Chief Executive Officer | Jul 07 | Open-market sale · S | −12,531 | $2.43 | −$30.5K | 293,059 |
| Keson-Brookes Maiken | See Remarks | Mar 05 | Open-market sale · S | −1,469 | $3.45 | −$5.07K | 73,564 |
| Loew Caroline | Chief Executive Officer | Mar 04 | Open-market sale · S | −4,313 | $3.36 | −$14.5K | 305,590 |
| Keson-Brookes Maiken | See Remarks | Mar 04 | Open-market sale · S | −1,262 | $3.36 | −$4.24K | 75,033 |
| Cutler Adam D. | Chief Financial Officer | Mar 03 | Grant / award · A | +35,000 | — | — | 106,438 |
| Goodman Vicki L | Chief Medical Officer | Mar 03 | Grant / award · A | +35,000 | — | — | 89,763 |
| Loew Caroline | Chief Executive Officer | Mar 03 | Grant / award · A | +72,275 | — | — | 309,903 |
| Keson-Brookes Maiken | See Remarks | Mar 03 | Grant / award · A | +35,000 | — | — | 76,295 |
| Goodman Vicki L | Chief Medical Officer | Feb 24 | Open-market sale · S | −13,186 | $3.89 | −$51.3K | 54,763 |
| Keson-Brookes Maiken | See Remarks | Dec 23 | Open-market sale · S | −2,555 | $3.27 | −$8.35K | 41,295 |
| Loew Caroline | Chief Executive Officer | Dec 17 | Open-market sale · S | −2,763 | $3.40 | −$9.39K | 237,628 |
| Goodman Vicki L | Chief Medical Officer | Nov 07 | Open-market sale · S | −5,069 | $3.33 | −$16.9K | 67,949 |
Loading...
